Humberside Police carried out almost 2,000 breath tests in two months


Throughout June and July Humberside Police, in partnership with Safer Roads Humber, carried out a summer campaign to raise awareness and reduce the incidence of drink and drug driving on our roads and reduce drink and drug drive related collisions and injuries.

During the campaign 387 breath tests were carried out following collisions on the roads of Humberside. A further 1,599 were carried out on drivers who were stopped by police officers.

Humberside Police Casualty Reduction Officer Barry Gardner: “We asked that anyone who suspected someone of drink driving through the period of the campaign, to call us. I was pleased with the result of this appeal and this intelligence-led approach helped us act on the information we receive.

Out of the 387 breath tests carried out following collisions 26 of them were classed as positive, refused or failed to provide.

Out of the 1,599 breath tests carried out on drivers stopped by officers 73 of them were classed as positive, refused or failed to provide.

During the campaign officers also tested drivers suspected of being under the influence of drugs using new testing kits following the changes to the drug drive law that came into force in England and Wales in March this year.

Fifteen drugs tests were carried out using the new testing kits, nine arrests were made following the tests. To date one of these tests has resulted in one offender being charged with drugs offences and will appear in court at a future date, other results are still pending outcomes.

The new law makes it illegal to drive with a specific controlled drug in the body above the accepted limit for that drug. This new law provides a more effective tool for police officers when dealing with the dangers posed by drug drivers.

PC Gardner added: “The new law helps reduce the time, expense and effort involved for the police and the courts when prosecutions fail because of the difficulty of proving that a driver is impaired by a particular drug under current legislation.”